Skip to content

Lung protection of perioperative pulmonary rehabilitation in lung cancer patients with moderate to severe COPD

Lung protection of perioperative pulmonary rehabilitation in lung cancer patients with moderate to severe COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093829
Enrollment
Unknown
Registered
2024-12-12
Start date
2022-07-09
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

intervention group:Patients in the intervention group received pulmonary rehabilitation (inspiratory muscle training + aerobic exercise + preoperative rehabilitation education) for 2 weeks before surg
control group:Patients in the control group received preoperative rehabilitation education, postoperative routine airway patency, early mobility, upper limb activity, etc.

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria are as follows: (i) diagnose with lung cancer through medical history, clinical symptoms, radiographic assessment and pathological results; (ii) Patients with no history of heart disease such as arrhythmia or myocardial infarction before surgery;(iii)to undergo minimally invasive lung cancer surgery (namely the video-assisted thoracoscopic surgery, VATS); (iv) preoperative pulmonary function examination was consistent with moderate COPD:FEV1/FVC<70%,50%<FEV1<80%; severe COPD:FEV1/FVC<70%, FEV1<50%; (v) with normal cognitive function and being able to cooperate with the rehab training; (vi) taken participation in the trial and signed the consent form.

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: (i)refuse the randomization; (ii) did not complete pulmonary rehabilitation training as required; (iii) with severe cognitive and mental dysfunctions; (iv) participated in other trials previously; (v)patients diagnosed with non-NSCLC after surgery;(vi)underwent total lung resection.

Design outcomes

Primary

MeasureTime frame
incidence of PPCs;

Secondary

MeasureTime frame
Inspiratory muscle strength;cardiorespiratory endurance;

Countries

China

Contacts

Public ContactJiaying Yang

The First Affiliated Hospital of Fujian Medical University

1297342930@qq.com+86 189 6093 9065

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 19, 2026